Impact of RTS,S/AS02_A and RTS,S/AS01_B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial

• John N. Waitumbi ,

  * E-mail: jwaitumbi@wrp-ksm.org

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Samuel B. Anyona,

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Carol W. Hunja,

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Carolyne M. Kifude,

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Mark E. Polhemus,

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Douglas S. Walsh,

  Affiliation Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya

  ⨯
• Chris F. Ockenhouse,

  Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, United States of America

  ⨯
• D. Gray Heppner Jr,

  Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research (WRAIR), Silver Spring, Maryland, United States of America

  ⨯
• Amanda Leach,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• Marc Lievens,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• W. Ripley Ballou,

  Current address: Infectious Diseases Development, Global Health Division, Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• Joe D. Cohen,

  Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium

  ⨯
• Colin J. Sutherland

  Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯